Structure-based Design of Dual Small-Molecule Inhibitors of Mdm2/Mdmx for Efficiently Reactivating P53 in Cancer Cells

被引：0
|
作者：
Su, Zhengding [1 ,2 ]
Duda, David [2 ]
Qin, Lingyun [1 ]
Chen, Yao [1 ]
Zhang, Huashan [1 ]
Wang, Weiping [1 ]
Schulman, Brenda [2 ]
机构：
[1] Hubei Univ Technol, Wuhan, Hubei, Peoples R China
[2] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
来源：
PROTEIN SCIENCE | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
10-69
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [21] Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy
    Tovar, C
    Rosinski, J
    Filipovic, Z
    Higgins, B
    Kolinsky, K
    Hilton, H
    Zhao, XL
    Vu, BT
    Qing, WG
    Packman, K
    Myklebost, O
    Heimbrook, DC
    Vassilev, LT
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (06) : 1888 - 1893
  • [22] Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
    Grinkevich, Vera V.
    Vema, Aparna
    Fawkner, Karin
    Issaeva, Natalia
    Andreotti, Virginia
    Dickinson, Eleanor R.
    Hedstrom, Elisabeth
    Spinnler, Clemens
    Inga, Alberto
    Larsson, Lars-Gunnar
    Karlen, Anders
    Wilhelm, Margareta
    Barran, Perdita E.
    Okorokov, Andrei L.
    Selivanova, Galina
    Zawacka-Pankau, Joanna E.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [23] Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
    Zhao, Yujun
    Aguilar, Angelo
    Bernard, Denzil
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (03) : 1038 - 1052
  • [24] KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
    Chutake, Yogesh K.
    Mayo, Michele F.
    Dumont, Nancy
    Filiatrault, Jessica
    Breitkopf, Susanne B.
    Cho, Patricia
    Chen, Dapeng
    Dixit, Vaishali S.
    Proctor, William R.
    Kuhn, Eric W.
    Martinez, Sarah Bollinger
    Mcdonald, Alice A.
    Qi, Jianfeng
    Hu, Kan-Nian
    Karnik, Rahul
    Growney, Joseph D.
    Sharma, Kirti
    Schalm, Stefanie S.
    Gollerkeri, Ashwin M.
    Mainolfi, Nello
    Williams, Juliet A.
    Weiss, Matthew M.
    MOLECULAR CANCER THERAPEUTICS, 2025, 24 (04) : 497 - 510
  • [25] Targeting p53-MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
    Zhu, Haohao
    Gao, Hui
    Ji, Yingying
    Zhou, Qin
    Du, Zhiqiang
    Tian, Lin
    Jiang, Ying
    Yao, Kun
    Zhou, Zhenhe
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [26] Small-molecule MDM2 inhibitors in clinical trials for cancer therapy
    Wang, Shuai
    Chen, Fen-Er
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 236
  • [27] Small-Molecule Inhibitors of the p53-MDM2 Interaction
    Vu, Binh T.
    Vassilev, Lyubomir
    SMALL-MOLECULE INHIBITORS OF PROTEIN-PROTEIN INTERACTIONS, 2011, 348 : 151 - 172
  • [28] Identification of MDMX/MDM2 metastasis signaling pathways in breast cancer cells with mutant p53
    Lee, Rusia
    Ellison, Viola
    Xiao, Gu
    Forbes, Dominique
    Leybengrub, Pam
    Kern, Alexandra
    Alexandre, Falande
    Annor, George
    Bargonetti, Jill
    CANCER RESEARCH, 2022, 82 (12)
  • [29] MDM2 inhibitors to reactivate p53 in human cancer
    Vassilev, L.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S6 - S6
  • [30] Discovery of Novel Antitumor Small-Molecule Agent with Dual Action of CDK2/p-RB and MDM2/p53
    Liu, Zhaofeng
    Yang, Yifei
    Sun, Xiaohui
    Ma, Runchen
    Zhang, Wenjing
    Wang, Wenyan
    Yang, Gangqiang
    Wang, Hongbo
    Zhang, Jianzhao
    Wang, Yunjie
    Tian, Jingwei
    MOLECULES, 2024, 29 (03):
12345